Net profit of Jubilant Pharmova rose 7432.81% to Rs 482.10 crore in the quarter ended June 2024 as against Rs 6.40 crore during the previous quarter ended June 2023. Sales rose 9.82% to Rs 1720.40 crore in the quarter ended June 2024 as against Rs 1566.50 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 1720.40 | 1566.50 | 10 |
| OPM % | 14.62 | 10.74 | - |
| PBDT | 194.50 | 114.90 | 69 |
| PBT | 103.80 | 25.20 | 312 |
| NP | 482.10 | 6.40 | 7433 |